Your Thyroid Medication Isn't Working Without These Cofactors.

DIO2 encodes deiodinase type 2, the enzyme responsible for converting thyroid hormone from its inactive storage form (T4) into its active form (T3). This conversion happens in your tissues, not your blood, which is why standard TSH testing misses it entirely. Your thyroid (or your medication) provides T4. DIO2 is responsible for flipping the switch that makes it useful.

If you carry the Ala/Ala variant at rs225014, your DIO2 enzyme works at a significantly reduced capacity. Roughly 12 to 15 percent of the population carries this variant. You can have perfectly normal TSH and T4 levels on paper while your tissues are functionally hypothyroid because your cells cannot convert the T4 you’re taking into the T3 they actually need. This is why some patients feel worlds better when switched to combination T3/T4 therapy or when T3 supplementation is added; they bypass the broken conversion step entirely.

Day-to-day, this feels like this: you take your levothyroxine faithfully, your TSH normalizes, but you still feel exhausted, mentally foggy, and cold. Your metabolism doesn’t speed up. Your weight doesn’t shift. Your hair keeps falling out. You feel like your thyroid medication is a placebo because, at the cellular level, it is. Your body has T4 in abundance but cannot unlock its active form.

VDR encodes the vitamin D receptor, the protein on your cell surface that pulls in vitamin D and initiates the signals that support immune function, calcium absorption, mitochondrial energy production, and thyroid hormone metabolism. Vitamin D is a cofactor for nearly every enzyme that processes thyroid hormone. If your cells cannot absorb it, your thyroid medication cannot work, no matter how much you supplement.

Variants in VDR (particularly at BsmI, FokI, and TaqI positions) are carried by roughly 30 to 50 percent of the population. People with VDR variants often experience functional vitamin D deficiency even when serum vitamin D levels are normal or even high, because their cells cannot pull in the vitamin D that’s circulating in their blood. You can take 4,000 IU of vitamin D daily, see your levels at 50 ng/mL (well above the minimum), and still feel the bone pain, immune dysfunction, and thyroid hormone metabolism problems of vitamin D deficiency. Your bloodwork and your symptoms don’t match because the VDR variant is preventing cellular uptake.

You might feel this as persistent fatigue despite supplementing, ongoing bone or muscle aches, poor wound healing, frequent infections, or worsening thyroid symptoms despite adequate T4 replacement. You may have noticed that vitamin D supplementation never seems to help, no matter the dose. That’s not laziness or bad luck. It’s genetics.

MTHFR encodes methylenetetrahydrofolate reductase, the enzyme that converts dietary folate into the active methylated form (5-methyltetrahydrofolate) your cells can use. Methylation is the master regulatory process in your body. It controls gene expression, immune tolerance, detoxification, neurotransmitter production, and thyroid hormone metabolism. Your thyroid antibodies (in autoimmune thyroid disease) are directly suppressed by methylation; inadequate methylation means thyroid antibodies remain elevated even while on thyroid medication.

The MTHFR C677T variant, carried by roughly 40 percent of people with European ancestry, reduces enzyme efficiency by 40 to 70 percent. People with this variant experience functional folate and B12 deficiency even on a folate-rich diet, which directly impairs methylation-dependent thyroid antibody suppression and thyroid hormone metabolism. Your cells are trying to run a complex chemical process on half fuel. Your thyroid medication addresses one problem (T4 replacement) but cannot overcome the methylation deficit that keeps thyroid antibodies elevated.

You might experience this as elevated thyroid antibodies (TPO and thyroglobulin) that don’t drop on medication, chronic fatigue, brain fog, mood dysregulation, elevated homocysteine on bloodwork, or recurring infections. If you have autoimmune thyroiditis (Hashimoto’s), this becomes especially important, because methylation dysfunction perpetuates the autoimmune attack even while hormone replacement is happening.

GC encodes the vitamin D binding protein (VDBP), the transport protein that carries vitamin D through your bloodstream and determines how much free (active) vitamin D is available to your cells versus how much is bound (inactive) in your blood. Your blood test measures total vitamin D, but what your cells actually use is the free fraction. Your GC variant directly determines that ratio.

GC variants (haplotypes 1s, 1f, and 2) are common in the population. Certain GC haplotypes bind vitamin D very tightly, leaving less free vitamin D available to tissues even when total serum vitamin D is adequate. You can supplement vitamin D, see a total level that looks healthy on paper, and still be functionally deficient at the cellular level because your VDBP variant is sequestering the vitamin in the bound, unusable form. This becomes especially problematic if you also have a VDR variant, because you have both reduced cellular uptake (VDR) and reduced free availability (GC).

You experience this as persistent thyroid symptoms, bone aches, muscle weakness, impaired immune function, or worsening autoimmune thyroid disease despite adequate supplementation. Standard vitamin D supplementation doesn’t seem to help because you’re not actually getting the vitamin to your cells, even though your blood levels look fine.

HFE encodes the hemochromatosis protein, which regulates iron absorption in your gut and prevents toxic iron accumulation. Iron is an essential cofactor for thyroid peroxidase (the enzyme that synthesizes thyroid hormones) and for many of the enzymes in the T4-to-T3 conversion cascade. Without adequate iron, your thyroid enzyme machinery cannot function, and your thyroid medication becomes ineffective regardless of dose.

The HFE H63D variant, carried by roughly 15 to 20 percent of people with European ancestry, is associated with mild iron dysregulation and reduced iron absorption. People with H63D variants often have lower iron status than their peers eating identical diets, and this iron insufficiency directly impairs thyroid hormone synthesis and conversion. You might have serum ferritin that looks adequate to your doctor but is actually inadequate for thyroid enzyme function. Your body cannot manufacture the cofactors your thyroid medication needs.

You might feel this as persistent fatigue despite thyroid medication, shortness of breath with exertion, poor exercise tolerance, thinning hair, or brain fog that doesn’t improve on increased T4 doses. Women are particularly susceptible because menstruation compounds iron loss; an HFE variant on top of monthly bleeding can leave you chronically iron-depleted without obvious signs.

BCMO1 encodes beta-carotene 15,15′-monooxygenase, the enzyme that converts plant-based beta-carotene into active retinol (vitamin A). Vitamin A is essential for thyroid hormone receptor function, immune tolerance (especially important in autoimmune thyroid disease), and mucous membrane integrity (which supports the gut barrier that prevents food-triggered thyroid antibody flares). Without adequate active vitamin A, your thyroid medication works in a hostile immune environment.

The BCMO1 R267S and A379V variants are carried by roughly 45 percent of the population. People with these variants have significantly reduced conversion of plant-based beta-carotene to retinol, meaning they need preformed vitamin A from animal sources or supplements rather than relying on plant conversion. You can eat plenty of carrots and sweet potatoes and kale, boost your beta-carotene intake, and still be vitamin A deficient because your body cannot convert what you’re eating into the usable form. Your thyroid medication is trying to function in an immune system that is vitamin A starved.

You might experience this as persistent thyroid antibodies despite adequate thyroid medication, frequent respiratory infections, poor gut barrier function (bloating, food sensitivities), or skin problems (dry skin, eczema, acne). If you have Hashimoto’s thyroiditis, vitamin A deficiency directly perpetuates the autoimmune attack, keeping you symptomatic despite hormone replacement.